169 related articles for article (PubMed ID: 34951635)
21. Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome.
Tosi F; Di Sarra D; Kaufman JM; Bonin C; Moretta R; Bonora E; Zanolin E; Moghetti P
J Clin Endocrinol Metab; 2015 Feb; 100(2):661-9. PubMed ID: 25393642
[TBL] [Abstract][Full Text] [Related]
22. Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age.
Guo Z; Jin F; Chen S; Hu P; Hao Y; Yu Q
BMC Endocr Disord; 2023 Apr; 23(1):89. PubMed ID: 37088815
[TBL] [Abstract][Full Text] [Related]
23. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
24. Hyperandrogenism by Liquid Chromatography Tandem Mass Spectrometry in PCOS: Focus on Testosterone and Androstenedione.
Grassi G; Polledri E; Fustinoni S; Chiodini I; Ceriotti F; D'Agostino S; Filippi F; Somigliana E; Mantovani G; Arosio M; Morelli V
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396396
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of total testosterone and free androgen index measured by LC-MS/MS for PCOS and insulin resistance.
Xu S; Liu Y; Xue K; Liu X; Jia G; Zeng Y; Chen Y
J Clin Lab Anal; 2022 Nov; 36(11):e24739. PubMed ID: 36258308
[TBL] [Abstract][Full Text] [Related]
26. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ
Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117
[TBL] [Abstract][Full Text] [Related]
27. Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome-Based on liquid chromatography with tandem mass spectrometry measurements.
Yang Y; Ding M; Di N; Azziz R; Yang D; Zhao X
J Clin Lab Anal; 2019 Mar; 33(3):e22699. PubMed ID: 30350882
[TBL] [Abstract][Full Text] [Related]
28. Insulin-Mediated Substrate Use in Women With Different Phenotypes of PCOS: the Role of Androgens.
Tosi F; Villani M; Migazzi M; Faccin G; Garofalo S; Fiers T; Kaufman JM; Bonora E; Moghetti P
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3414-e3425. PubMed ID: 34050757
[TBL] [Abstract][Full Text] [Related]
29. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
[TBL] [Abstract][Full Text] [Related]
30. Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome.
Bui HN; Sluss PM; Hayes FJ; Blincko S; Knol DL; Blankenstein MA; Heijboer AC
Clin Chim Acta; 2015 Oct; 450():227-32. PubMed ID: 26327459
[TBL] [Abstract][Full Text] [Related]
31. Steroid Hormone Profiling in Hyperandrogenism and Non-hyperandrogenism Women with Polycystic Ovary Syndrome.
Ge J; Yang N; Zhang X; Li M; Zhang W; He J; Zhu H; Cheng X; Shen S; Ge W
Reprod Sci; 2022 Dec; 29(12):3449-3458. PubMed ID: 35835901
[TBL] [Abstract][Full Text] [Related]
32. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
[TBL] [Abstract][Full Text] [Related]
33. Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?
Li S; Chu Q; Ma J; Sun Y; Tao T; Huang R; Liao Y; Yue J; Zheng J; Wang L; Xue X; Zhu M; Kang X; Yin H; Liu W
J Clin Endocrinol Metab; 2017 Mar; 102(3):810-821. PubMed ID: 27886515
[TBL] [Abstract][Full Text] [Related]
34. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T
Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253
[TBL] [Abstract][Full Text] [Related]
35. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
36. Free androgen index and Irisin in polycystic ovary syndrome.
Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
[TBL] [Abstract][Full Text] [Related]
37. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
Barth JH; Field HP; Yasmin E; Balen AH
Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
[TBL] [Abstract][Full Text] [Related]
38. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[TBL] [Abstract][Full Text] [Related]
39. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
O'Reilly MW; Taylor AE; Crabtree NJ; Hughes BA; Capper F; Crowley RK; Stewart PM; Tomlinson JW; Arlt W
J Clin Endocrinol Metab; 2014 Mar; 99(3):1027-36. PubMed ID: 24423344
[TBL] [Abstract][Full Text] [Related]
40. Association between circulating zinc-α2-glycoprotein levels and the different phenotypes of polycystic ovary syndrome.
Tang C; Li X; Tang S; Wang Y; Tan X
Endocr J; 2020 Mar; 67(3):249-255. PubMed ID: 31748429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
